Gene: GPC6
Official Full Name: glypican 6provided by HGNC
Gene Summary: The glypicans comprise a family of glycosylphosphatidylinositol-anchored heparan sulfate proteoglycans, and they have been implicated in the control of cell growth and cell division. The glypican encoded by this gene is a putative cell surface coreceptor for growth factors, extracellular matrix proteins, proteases and anti-proteases. Mutations in this gene are associated with omodysplasia 1. [provided by RefSeq, Nov 2016]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO05258 | GPC6 Knockout cell line (HEK293) | Human | GPC6 | 1:3~1:6 | Negative | Online Inquiry |
KO05259 | GPC6 Knockout cell line (A549) | Human | GPC6 | 1:3~1:4 | Negative | Online Inquiry |
GPC6 Gene Knockout Cell Lines represent a vital tool in molecular biology involving the engineered disruption of the glypican-6 (GPC6) gene, a member of the glypican family of heparan sulfate proteoglycans that play significant roles in cell signaling and development. The GPC6 gene knockout is achieved through advanced gene editing techniques, such as CRISPR/Cas9, which introduce precise mutations leading to the complete loss of GPC6 expression. This allows researchers to investigate the gene’s function and its implications in various biological processes, including cell proliferation, differentiation, and tumorigenesis.
The key mechanism underpinning the use of these knockout cell lines lies in their ability to serve as a model for studying GPC6's role in cellular microenvironments and its contribution to pathological conditions. By utilizing GPC6 knockout cell lines, scientists can explore potential therapeutic pathways and identify novel biomarkers associated with diseases, particularly certain cancers, where glypicans are implicated. These cell lines are invaluable in drug discovery and development, providing insights into drug-target interactions and cellular responses.
Compared to alternative models, such as transient knockdown or other gene knockout strategies, GPC6 Gene Knockout Cell Lines offer the advantage of stable genetic alteration, ensuring consistent expression levels over extended periods, which enhances reproducibility in experimental outcomes. This stability is crucial for longitudinal studies and extended applications in preclinical research.
The value of GPC6 Gene Knockout Cell Lines extends beyond basic research; their application in clinical settings aids in understanding how genetic variations can influence disease mechanisms and treatment efficacy. As a result, these cell lines serve as a bridge between laboratory findings and potential clinical applications, making them indispensable tools for both researchers and clinicians.
Our company specializes in producing high-quality biological products developed with cutting-edge techniques and a commitment to scientific excellence. By providing reliable and validated GPC6 Gene Knockout Cell Lines, we empower researchers to unravel the complexities of human health and disease, facilitating innovations that can lead to breakthroughs in therapeutic strategies.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.